Clinical Trials List
2016-12-29 - 2023-09-28
Phase III
Recruiting6
Terminated2
ICD-10C50
Malignant neoplasm of breast
ICD-10C79.81
Secondary malignant neoplasm of breast
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
GNT Biotech & Medicals Corporation,
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- CHIN-SHENG HUNG Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 方嘉郎 Division of Others
- Wei-Wen Chang Division of General Surgery
- Chia-Lun Chang Division of Hematology & Oncology
- Mao-Chih Hsieh Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-Chung Wu Division of General Surgery
- Chen-Teng Wu Division of General Surgery
- Chih-Jung Chen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- Wei-Hong Cheng Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
- Tsu-Yi Chao Division of Hematology & Oncology
- 蘇勇誠 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
11 Recruiting
Audit
None
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Junping Shiau Shiau Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- Ming-Feng Hou Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
55 participants
-
Global
420 participants
